Buy Engineers India, target price Rs 96.5 : HDFC SecuritiesEngineers India, incorporated in the year 1965, is a Mid Cap company (having a market cap of Rs 4746.45 Crore) operating in Services sector.
Former RBI deputy governor BP Kanungo, Kaushik Dutta join BharatPe boardThe appointments are in line with the company’s aim to strengthen its corporate governance practices, it said on Tuesday.
Buy EIL, target price Rs 126: Kunal BothraKunal Bothra recommended to keep a stop loss at Rs 115.
Buy Engineers India, target Rs 112: Kunal BothraBuy Engineers India Ltd. at a price target of Rs 112.0 and a stoploss at Rs 102 from entry point.
Sell Engineers India, target Rs 102: Manas JaiswalSell Engineers India Ltd. at a price target of Rs 102.0 and a stoploss at Rs 111 from entry point.
BoB eyes Rs 4,000 crore gains from fintech by FY20The bank expects to close FY19 with a fintech business turnover of Rs 1,200 crore.
Social networking site 'ChefHost' for chefs to rustle up that perfect gourmet dinnerChefHost, an online peer-to-peer marketplace and community connects chefs and hosts for private dining and exclusive catering services.
LS polls 2014: Many former IAS, IPS officers in frayBe it arch rivals BJP and Congress or newbie Aam Aadmi Party (AAP), each of them have fielded a number of retired bureaucrats to win over p...
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%
Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Claris promoter sells 12 lakh shares for over Rs 23 crore
Claris Lifesciences promoter Aditya Sushil Kumar Handa today offloaded nearly 12 lakh shares of the pharma company for over Rs 23 crore.
Pfizer ends supply deal with Claris LifesciencesMultinational drug-maker Pfizer Inc has terminated its three-year old supply deal with Claris Lifesciences, immediately after a ban on the ...
- Morgan Stanley, Barclays buy Claris bulk shares in open market on USFDA clearance
Claris said it has formally received the letter from USFDA stating that it has completed its evaluation of the firm's corrective actions.
- Claris Lifesciences promoter sells 10 lakh shares
Aditya Sushil Kumar Handa, one of the promoters of Claris Lifesciences, today sold 10 lakh shares of the drug company.
- Claris Lifesciences net profit falls 14%, USFDA clearance awaiting
The consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Claris Lifesciences promoter offloads over 17 lakh shares
Aditya Sushil Kumar Handa, one of the promoters of Claris Lifesciences, today sold over 17.33 lakh shares of the drug company for Rs 28 cro...
- Kamal Chauhan, former RSS worker planted bombs on Samjhauta Express: NIA
Kamal Chauhan, a disgruntled RSS worker arrested by the NIA, had planted bombs on board Samjhauta Express in 2007 after undergoing training...
- Multiplexes expect flop show in Q4
Multiplex chains are bracing to end the current quarter with an exceptionally low business as occupancies have been lower than expected due...